• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.

作者信息

Ahlijanian M K, Takemori A E

出版信息

Life Sci. 1986 Feb 17;38(7):577-88. doi: 10.1016/0024-3205(86)90051-2.

DOI:10.1016/0024-3205(86)90051-2
PMID:3003486
Abstract

Chronic administration of caffeine to mice (1 mg/ml in drinking water X 14 d) led to a downward shift in the dose-response curve for the locomotor effects of caffeine. Caffeine was also less effective as an antagonist against (-)-(N6-phenylisopropyl)-adenosine (PIA)-induced analgesia in the tail flick assay in these animals. The dose-response curves of PIA for both analgesia and locomotor depression were shifted to the left in animals chronically administered caffeine. In mice chronically administered PIA (1 mg/kg/d X 14 d), the dose-response curves of PIA for both analgesia and locomotor depression were shifted to the right. The dose-response curve for the locomotor effects of caffeine was shifted to the left, and caffeine exhibited greater antagonist activity against the analgesic action of PIA in these animals. There was no change in the Kd or Bmax values of either 3H-PIA or 3H-diethylphenylxanthine (DPX, a potent adenosine receptor antagonist) in mice chronically administered PIA. The Bmax values for both 3H-PIA and 3H-DPX were significantly increased, while the Kd values were not changed in mice chronically administered caffeine. There was no detectable change in the brain levels of either PIA or caffeine in animals chronically treated with either drug. The results demonstrate that chronic administration of caffeine increases the sensitivity of mice to the actions of PIA and vice versa, providing supportive evidence for the interaction of these drugs at the same receptor, which is probably an adenosine receptor.

摘要

相似文献

1
Cross-tolerance studies between caffeine and (-)-N6-(phenylisopropyl)-adenosine (PIA) in mice.
Life Sci. 1986 Feb 17;38(7):577-88. doi: 10.1016/0024-3205(86)90051-2.
2
Changes in adenosine receptor sensitivity in morphine-tolerant and -dependent mice.
J Pharmacol Exp Ther. 1986 Mar;236(3):615-20.
3
Effects of (-)-N6-(R-phenylisopropyl)-adenosine (PIA) and caffeine on nociception and morphine-induced analgesia, tolerance and dependence in mice.(-)-N6-(R-苯异丙基)-腺苷(PIA)和咖啡因对小鼠伤害感受及吗啡诱导的镇痛、耐受性和依赖性的影响。
Eur J Pharmacol. 1985 Jun 7;112(2):171-9. doi: 10.1016/0014-2999(85)90493-5.
4
Stereoselective behavioral effects of N6-phenylisopropyl-adenosine and antagonism by caffeine.N6-苯基异丙基腺苷的立体选择性行为效应及咖啡因的拮抗作用。
Psychopharmacology (Berl). 1985;87(3):272-7. doi: 10.1007/BF00432706.
5
The effect of chronic administration of caffeine on morphine-induced analgesia, tolerance and dependence in mice.长期给予咖啡因对小鼠吗啡诱导的镇痛、耐受性及依赖性的影响。
Eur J Pharmacol. 1986 Jan 14;120(1):25-32. doi: 10.1016/0014-2999(86)90635-7.
6
Tolerance to N6-(L-phenylisopropyl) adenosine. Contribution of behavioral mechanisms and cross-tolerance profile.对N6-(L-苯异丙基)腺苷的耐受性。行为机制的作用和交叉耐受性概况。
Neuropharmacology. 1984 Jun;23(6):671-6. doi: 10.1016/0028-3908(84)90149-7.
7
Interactions in the behavioral effects of methylxanthines and adenosine derivatives.甲基黄嘌呤与腺苷衍生物行为效应中的相互作用。
J Pharmacol Exp Ther. 1983 Oct;227(1):167-73.
8
Tolerance and cross-tolerance to theophylline-induced stimulation of locomotor activity in rats.
Life Sci. 1988;42(24):2475-82. doi: 10.1016/0024-3205(88)90346-3.
9
Discriminative stimulus properties of L-phenylisopropyl adenosine: blockade by caffeine and generalization to 2-chloroadenosine.
Life Sci. 1983 May 16;32(20):2329-33. doi: 10.1016/0024-3205(83)90762-2.
10
Effects of adenosine analogs alone and in combination with caffeine in the squirrel monkey.腺苷类似物单独及与咖啡因联合应用对松鼠猴的影响。
Pharmacol Biochem Behav. 1988 Feb;29(2):429-32. doi: 10.1016/0091-3057(88)90181-5.

引用本文的文献

1
Effects of Combinations of Methylxanthines and Adenosine Analogs on Locomotor Activity in Control and Chronic Caffeine-Treated Mice.甲基黄嘌呤与腺苷类似物组合对正常及长期咖啡因处理小鼠运动活性的影响
Drug Dev Res. 1993 Oct;30(2):104-110. doi: 10.1002/ddr.430300209.
2
The role of adenosine receptors in the central action of caffeine.腺苷受体在咖啡因中枢作用中的角色。
Pharmacopsychoecologia. 1994;7(2):201-213.
3
Adenosine receptor ligands: differences with acute versus chronic treatment.腺苷受体配体:急性治疗与慢性治疗的差异
Trends Pharmacol Sci. 1996 Mar;17(3):108-13. doi: 10.1016/0165-6147(96)10002-x.
4
Effect of long term caffeine treatment on A1 and A2 adenosine receptor binding and on mRNA levels in rat brain.长期咖啡因治疗对大鼠脑内A1和A2腺苷受体结合及mRNA水平的影响。
Naunyn Schmiedebergs Arch Pharmacol. 1993 Apr;347(4):407-14. doi: 10.1007/BF00165391.
5
Chronic caffeine alters the density of adenosine, adrenergic, cholinergic, GABA, and serotonin receptors and calcium channels in mouse brain.长期摄入咖啡因会改变小鼠大脑中腺苷、肾上腺素能、胆碱能、γ-氨基丁酸(GABA)和5-羟色胺受体以及钙通道的密度。
Cell Mol Neurobiol. 1993 Jun;13(3):247-61. doi: 10.1007/BF00733753.
6
Pharmacological rationale for the clinical use of caffeine.咖啡因临床应用的药理学依据。
Drugs. 1995 Jan;49(1):37-50. doi: 10.2165/00003495-199549010-00004.
7
Locomotor activity in mice during chronic treatment with caffeine and withdrawal.咖啡因长期治疗及撤药期间小鼠的运动活动
Pharmacol Biochem Behav. 1993 Jan;44(1):199-216. doi: 10.1016/0091-3057(93)90299-9.
8
Multiple components of the A1 adenosine receptor-adenylate cyclase system are regulated in rat cerebral cortex by chronic caffeine ingestion.慢性摄入咖啡因可调节大鼠大脑皮层中A1腺苷受体-腺苷酸环化酶系统的多个组分。
J Clin Invest. 1988 Jul;82(1):242-7. doi: 10.1172/JCI113577.
9
Caffeine physical dependence: a review of human and laboratory animal studies.咖啡因身体依赖性:对人类和实验动物研究的综述
Psychopharmacology (Berl). 1988;94(4):437-51. doi: 10.1007/BF00212836.
10
Pharmacologic specificity of tolerance to caffeine-induced stimulation of locomotor activity.
Psychopharmacology (Berl). 1987;93(4):428-34. doi: 10.1007/BF00207230.